Yi Ching Yau - 07 Jun 2022 Form 4 Insider Report for ChemoCentryx, Inc.

Reporting relationship: SVP, Finance & Acctg Officer
Issuer ticker: N/A
Reported as of: 07 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2022, 18:33:46 UTC
Prior SEC filing: 08 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Susan M. Kanaya, as Attorney-in-Fact

Key filing fact

Yi Ching Yau filed Form 4 for ChemoCentryx, Inc. on 08 Jun 2022.

Key facts

This page summarizes Yi Ching Yau's Form 4 filing for ChemoCentryx, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2022, 18:33.

Change

Previous filing in this sequence was filed on 08 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CCXI transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +65,000
Change %
Price
Shares after: 65,000
Date: 07 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $25.19
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option was granted on June 7, 2022, and 25% of the total number of shares of common stock subject to the option vests on June 6, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.

Footnote F2

Not applicable.